Chromatography Columns Market

ID: MRFR/HC/9183-HCR
120 Pages
Rahul Gotadki
Last Updated: April 06, 2026
Chromatography Columns Market Research Report By Column Type (Normal Phase Chromatography Columns, Prepacked Chromatography Columns, Automated Chromatography Columns), By Chromatography Type (Ion Exchange Chromatography, Affinity Chromatography, Gas Chromatography, Size Exclusion Chromatography), By Application (Anion & Cation Exchange, Sample Preparation, Resin Screening, Protein Purification, Desalting), By End User (Research Institutes, Pharmaceutical Biotechnology Companies, Food & Beverage Manufacturers and others), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Column Type (USD Billion) | |
      1. 4.1.1 Normal Phase Chromatography Columns | |
      2. 4.1.2 Prepacked Chromatography Columns | |
      3. 4.1.3 Automated Chromatography Columns |
    2. 4.2 Healthcare, BY Chromatography Type (USD Billion) | |
      1. 4.2.1 Ion Exchange Chromatography | |
      2. 4.2.2 Affinity Chromatography | |
      3. 4.2.3 Gas Chromatography | |
      4. 4.2.4 Size Exclusion Chromatography |
    3. 4.3 Healthcare, BY Application (USD Billion) | |
      1. 4.3.1 Anion & Cation Exchange | |
      2. 4.3.2 Sample Preparation | |
      3. 4.3.3 Resin Screening | |
      4. 4.3.4 Protein Purification | |
      5. 4.3.5 Desalting |
    4. 4.4 Healthcare, BY End User (USD Billion) | |
      1. 4.4.1 Research Institutes | |
      2. 4.4.2 Pharmaceutical Biotechnology Companies | |
      3. 4.4.3 Food & Beverage Manufacturers | |
      4. 4.4.4 Others |
    5. 4.5 Healthcare, BY Region (USD Billion) | |
      1. 4.5.1 North America | | |
        1. 4.5.1.1 US | | |
        2. 4.5.1.2 Canada | |
      2. 4.5.2 Europe | | |
        1. 4.5.2.1 Germany | | |
        2. 4.5.2.2 UK | | |
        3. 4.5.2.3 France | | |
        4. 4.5.2.4 Russia | | |
        5. 4.5.2.5 Italy | | |
        6. 4.5.2.6 Spain | | |
        7. 4.5.2.7 Rest of Europe | |
      3. 4.5.3 APAC | | |
        1. 4.5.3.1 China | | |
        2. 4.5.3.2 India | | |
        3. 4.5.3.3 Japan | | |
        4. 4.5.3.4 South Korea | | |
        5. 4.5.3.5 Malaysia | | |
        6. 4.5.3.6 Thailand | | |
        7. 4.5.3.7 Indonesia | | |
        8. 4.5.3.8 Rest of APAC | |
      4. 4.5.4 South America | | |
        1. 4.5.4.1 Brazil | | |
        2. 4.5.4.2 Mexico | | |
        3. 4.5.4.3 Argentina | | |
        4. 4.5.4.4 Rest of South America | |
      5. 4.5.5 MEA | | |
        1. 4.5.5.1 GCC Countries | | |
        2. 4.5.5.2 South Africa | | |
        3. 4.5.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Agilent Technologies (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Thermo Fisher Scientific (US) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Waters Corporation (US) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Merck KGaA (DE) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 PerkinElmer (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Shimadzu Corporation (JP) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Sartorius AG (DE) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Bio-Rad Laboratories (US) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies | |
      9. 5.2.9 GE Healthcare (US) | | |
        1. 5.2.9.1 Financial Overview | | |
        2. 5.2.9.2 Products Offered | | |
        3. 5.2.9.3 Key Developments | | |
        4. 5.2.9.4 SWOT Analysis | | |
        5. 5.2.9.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY COLUMN TYPE |
    7. 6.4 US MARKET ANALYSIS BY CHROMATOGRAPHY TYPE |
    8. 6.5 US MARKET ANALYSIS BY APPLICATION |
    9. 6.6 US MARKET ANALYSIS BY END USER |
    10. 6.7 CANADA MARKET ANALYSIS BY COLUMN TYPE |
    11. 6.8 CANADA MARKET ANALYSIS BY CHROMATOGRAPHY TYPE |
    12. 6.9 CANADA MARKET ANALYSIS BY APPLICATION |
    13. 6.10 CANADA MARKET ANALYSIS BY END USER |
    14. 6.11 EUROPE MARKET ANALYSIS |
    15. 6.12 GERMANY MARKET ANALYSIS BY COLUMN TYPE |
    16. 6.13 GERMANY MARKET ANALYSIS BY CHROMATOGRAPHY TYPE |
    17. 6.14 GERMANY MARKET ANALYSIS BY APPLICATION |
    18. 6.15 GERMANY MARKET ANALYSIS BY END USER |
    19. 6.16 UK MARKET ANALYSIS BY COLUMN TYPE |
    20. 6.17 UK MARKET ANALYSIS BY CHROMATOGRAPHY TYPE |
    21. 6.18 UK MARKET ANALYSIS BY APPLICATION |
    22. 6.19 UK MARKET ANALYSIS BY END USER |
    23. 6.20 FRANCE MARKET ANALYSIS BY COLUMN TYPE |
    24. 6.21 FRANCE MARKET ANALYSIS BY CHROMATOGRAPHY TYPE |
    25. 6.22 FRANCE MARKET ANALYSIS BY APPLICATION |
    26. 6.23 FRANCE MARKET ANALYSIS BY END USER |
    27. 6.24 RUSSIA MARKET ANALYSIS BY COLUMN TYPE |
    28. 6.25 RUSSIA MARKET ANALYSIS BY CHROMATOGRAPHY TYPE |
    29. 6.26 RUSSIA MARKET ANALYSIS BY APPLICATION |
    30. 6.27 RUSSIA MARKET ANALYSIS BY END USER |
    31. 6.28 ITALY MARKET ANALYSIS BY COLUMN TYPE |
    32. 6.29 ITALY MARKET ANALYSIS BY CHROMATOGRAPHY TYPE |
    33. 6.30 ITALY MARKET ANALYSIS BY APPLICATION |
    34. 6.31 ITALY MARKET ANALYSIS BY END USER |
    35. 6.32 SPAIN MARKET ANALYSIS BY COLUMN TYPE |
    36. 6.33 SPAIN MARKET ANALYSIS BY CHROMATOGRAPHY TYPE |
    37. 6.34 SPAIN MARKET ANALYSIS BY APPLICATION |
    38. 6.35 SPAIN MARKET ANALYSIS BY END USER |
    39. 6.36 REST OF EUROPE MARKET ANALYSIS BY COLUMN TYPE |
    40. 6.37 REST OF EUROPE MARKET ANALYSIS BY CHROMATOGRAPHY TYPE |
    41. 6.38 REST OF EUROPE MARKET ANALYSIS BY APPLICATION |
    42. 6.39 REST OF EUROPE MARKET ANALYSIS BY END USER |
    43. 6.40 APAC MARKET ANALYSIS |
    44. 6.41 CHINA MARKET ANALYSIS BY COLUMN TYPE |
    45. 6.42 CHINA MARKET ANALYSIS BY CHROMATOGRAPHY TYPE |
    46. 6.43 CHINA MARKET ANALYSIS BY APPLICATION |
    47. 6.44 CHINA MARKET ANALYSIS BY END USER |
    48. 6.45 INDIA MARKET ANALYSIS BY COLUMN TYPE |
    49. 6.46 INDIA MARKET ANALYSIS BY CHROMATOGRAPHY TYPE |
    50. 6.47 INDIA MARKET ANALYSIS BY APPLICATION |
    51. 6.48 INDIA MARKET ANALYSIS BY END USER |
    52. 6.49 JAPAN MARKET ANALYSIS BY COLUMN TYPE |
    53. 6.50 JAPAN MARKET ANALYSIS BY CHROMATOGRAPHY TYPE |
    54. 6.51 JAPAN MARKET ANALYSIS BY APPLICATION |
    55. 6.52 JAPAN MARKET ANALYSIS BY END USER |
    56. 6.53 SOUTH KOREA MARKET ANALYSIS BY COLUMN TYPE |
    57. 6.54 SOUTH KOREA MARKET ANALYSIS BY CHROMATOGRAPHY TYPE |
    58. 6.55 SOUTH KOREA MARKET ANALYSIS BY APPLICATION |
    59. 6.56 SOUTH KOREA MARKET ANALYSIS BY END USER |
    60. 6.57 MALAYSIA MARKET ANALYSIS BY COLUMN TYPE |
    61. 6.58 MALAYSIA MARKET ANALYSIS BY CHROMATOGRAPHY TYPE |
    62. 6.59 MALAYSIA MARKET ANALYSIS BY APPLICATION |
    63. 6.60 MALAYSIA MARKET ANALYSIS BY END USER |
    64. 6.61 THAILAND MARKET ANALYSIS BY COLUMN TYPE |
    65. 6.62 THAILAND MARKET ANALYSIS BY CHROMATOGRAPHY TYPE |
    66. 6.63 THAILAND MARKET ANALYSIS BY APPLICATION |
    67. 6.64 THAILAND MARKET ANALYSIS BY END USER |
    68. 6.65 INDONESIA MARKET ANALYSIS BY COLUMN TYPE |
    69. 6.66 INDONESIA MARKET ANALYSIS BY CHROMATOGRAPHY TYPE |
    70. 6.67 INDONESIA MARKET ANALYSIS BY APPLICATION |
    71. 6.68 INDONESIA MARKET ANALYSIS BY END USER |
    72. 6.69 REST OF APAC MARKET ANALYSIS BY COLUMN TYPE |
    73. 6.70 REST OF APAC MARKET ANALYSIS BY CHROMATOGRAPHY TYPE |
    74. 6.71 REST OF APAC MARKET ANALYSIS BY APPLICATION |
    75. 6.72 REST OF APAC MARKET ANALYSIS BY END USER |
    76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
    77. 6.74 BRAZIL MARKET ANALYSIS BY COLUMN TYPE |
    78. 6.75 BRAZIL MARKET ANALYSIS BY CHROMATOGRAPHY TYPE |
    79. 6.76 BRAZIL MARKET ANALYSIS BY APPLICATION |
    80. 6.77 BRAZIL MARKET ANALYSIS BY END USER |
    81. 6.78 MEXICO MARKET ANALYSIS BY COLUMN TYPE |
    82. 6.79 MEXICO MARKET ANALYSIS BY CHROMATOGRAPHY TYPE |
    83. 6.80 MEXICO MARKET ANALYSIS BY APPLICATION |
    84. 6.81 MEXICO MARKET ANALYSIS BY END USER |
    85. 6.82 ARGENTINA MARKET ANALYSIS BY COLUMN TYPE |
    86. 6.83 ARGENTINA MARKET ANALYSIS BY CHROMATOGRAPHY TYPE |
    87. 6.84 ARGENTINA MARKET ANALYSIS BY APPLICATION |
    88. 6.85 ARGENTINA MARKET ANALYSIS BY END USER |
    89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY COLUMN TYPE |
    90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY CHROMATOGRAPHY TYPE |
    91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
    92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER |
    93. 6.90 MEA MARKET ANALYSIS |
    94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY COLUMN TYPE |
    95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY CHROMATOGRAPHY TYPE |
    96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION |
    97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY END USER |
    98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY COLUMN TYPE |
    99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY CHROMATOGRAPHY TYPE |
    100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION |
    101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY END USER |
    102. 6.99 REST OF MEA MARKET ANALYSIS BY COLUMN TYPE |
    103. 6.100 REST OF MEA MARKET ANALYSIS BY CHROMATOGRAPHY TYPE |
    104. 6.101 REST OF MEA MARKET ANALYSIS BY APPLICATION |
    105. 6.102 REST OF MEA MARKET ANALYSIS BY END USER |
    106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
    107. 6.104 RESEARCH PROCESS OF MRFR |
    108. 6.105 DRO ANALYSIS OF HEALTHCARE |
    109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
    112. 6.109 HEALTHCARE, BY COLUMN TYPE, 2024 (% SHARE) |
    113. 6.110 HEALTHCARE, BY COLUMN TYPE, 2024 TO 2035 (USD Billion) |
    114. 6.111 HEALTHCARE, BY CHROMATOGRAPHY TYPE, 2024 (% SHARE) |
    115. 6.112 HEALTHCARE, BY CHROMATOGRAPHY TYPE, 2024 TO 2035 (USD Billion) |
    116. 6.113 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
    117. 6.114 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion) |
    118. 6.115 HEALTHCARE, BY END USER, 2024 (% SHARE) |
    119. 6.116 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion) |
    120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    121. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.2.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.2.4 BY END USER, 2025-2035 (USD Billion) |
    123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.3.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.3.4 BY END USER, 2025-2035 (USD Billion) |
    124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.4.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.4.4 BY END USER, 2025-2035 (USD Billion) |
    125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.5.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.5.4 BY END USER, 2025-2035 (USD Billion) |
    126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.6.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.6.4 BY END USER, 2025-2035 (USD Billion) |
    127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.7.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.7.4 BY END USER, 2025-2035 (USD Billion) |
    128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.8.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.8.4 BY END USER, 2025-2035 (USD Billion) |
    129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.9.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.9.4 BY END USER, 2025-2035 (USD Billion) |
    130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.10.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.10.4 BY END USER, 2025-2035 (USD Billion) |
    131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.11.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.11.4 BY END USER, 2025-2035 (USD Billion) |
    132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.12.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.12.4 BY END USER, 2025-2035 (USD Billion) |
    133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.13.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.13.4 BY END USER, 2025-2035 (USD Billion) |
    134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.14.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.14.4 BY END USER, 2025-2035 (USD Billion) |
    135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.15.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.15.4 BY END USER, 2025-2035 (USD Billion) |
    136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.16.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.16.4 BY END USER, 2025-2035 (USD Billion) |
    137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.17.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.17.4 BY END USER, 2025-2035 (USD Billion) |
    138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.18.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.18.4 BY END USER, 2025-2035 (USD Billion) |
    139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.19.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.19.4 BY END USER, 2025-2035 (USD Billion) |
    140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.20.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.20.4 BY END USER, 2025-2035 (USD Billion) |
    141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.21.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.21.4 BY END USER, 2025-2035 (USD Billion) |
    142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.22.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.22.4 BY END USER, 2025-2035 (USD Billion) |
    143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.23.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.23.4 BY END USER, 2025-2035 (USD Billion) |
    144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.24.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.24.4 BY END USER, 2025-2035 (USD Billion) |
    145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.25.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.25.4 BY END USER, 2025-2035 (USD Billion) |
    146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.26.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.26.4 BY END USER, 2025-2035 (USD Billion) |
    147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.27.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.27.4 BY END USER, 2025-2035 (USD Billion) |
    148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.28.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.28.4 BY END USER, 2025-2035 (USD Billion) |
    149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.29.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.29.4 BY END USER, 2025-2035 (USD Billion) |
    150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY COLUMN TYPE, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Billion) | |
      3. 7.30.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.30.4 BY END USER, 2025-2035 (USD Billion) |
    151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    152. 7.32 ACQUISITION/PARTNERSHIP | |

Healthcare Market Segmentation

Healthcare By Column Type (USD Billion, 2025-2035)

  • Normal Phase Chromatography Columns
  • Prepacked Chromatography Columns
  • Automated Chromatography Columns

Healthcare By Chromatography Type (USD Billion, 2025-2035)

  • Ion Exchange Chromatography
  • Affinity Chromatography
  • Gas Chromatography
  • Size Exclusion Chromatography

Healthcare By Application (USD Billion, 2025-2035)

  • Anion & Cation Exchange
  • Sample Preparation
  • Resin Screening
  • Protein Purification
  • Desalting

Healthcare By End User (USD Billion, 2025-2035)

  • Research Institutes
  • Pharmaceutical Biotechnology Companies
  • Food & Beverage Manufacturers
  • Others